| Joseph A Hilinski, MD | |
|
305 E Jefferson St, Boise, ID 83712-6273 | |
| (208) 381-7330 | |
| (208) 381-7331 |
| Full Name | Joseph A Hilinski |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Infectious Diseases |
| Location | 305 E Jefferson St, Boise, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649212077 | NPI | - | NPPES |
| 741243318A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0208X | Pediatrics - Pediatric Infectious Diseases | 046121 (Georgia) | Primary |
| Entity Name | Emory Medical Care Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063452381 PECOS PAC ID: 4981501814 Enrollment ID: O20031217000968 |
News Archive
Vemma has updated the Verve brand packaging to better align with the company's modern, premium and healthy look and feel. Rebranding projects included both Verve Energy Drink and Verve Energy Shot.
The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.
Pfizer Inc. today announced the commencement of a tender offer by its wholly owned subsidiary, Parker Tennessee Corp., for all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
"In the Horn of Africa, millions of people face each day without knowing if they will have clean water to drink or food to eat," but "American assistance to the Horn of Africa is beginning to make a difference, however, and in this series about water security in the Horn, we will showcase how water projects are helping people gain predictable access to clean water as a first step to gaining a foothold on a better life."
A new study suggests a growing number of U.S. adolescents lack antibodies that may help protect them later in life against an increasingly important cause of genital herpes. Published in The Journal of Infectious Diseases and available online, the findings show that fewer of today's teens have been exposed in their childhood to herpes simplex virus type 1 (HSV-1), a common cause of cold sores, than U.S. adolescents in previous years.
› Verified 3 days ago
| Entity Name | Choa Multispecialty, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437493467 PECOS PAC ID: 7719126820 Enrollment ID: O20130621000413 |
News Archive
Vemma has updated the Verve brand packaging to better align with the company's modern, premium and healthy look and feel. Rebranding projects included both Verve Energy Drink and Verve Energy Shot.
The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.
Pfizer Inc. today announced the commencement of a tender offer by its wholly owned subsidiary, Parker Tennessee Corp., for all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
"In the Horn of Africa, millions of people face each day without knowing if they will have clean water to drink or food to eat," but "American assistance to the Horn of Africa is beginning to make a difference, however, and in this series about water security in the Horn, we will showcase how water projects are helping people gain predictable access to clean water as a first step to gaining a foothold on a better life."
A new study suggests a growing number of U.S. adolescents lack antibodies that may help protect them later in life against an increasingly important cause of genital herpes. Published in The Journal of Infectious Diseases and available online, the findings show that fewer of today's teens have been exposed in their childhood to herpes simplex virus type 1 (HSV-1), a common cause of cold sores, than U.S. adolescents in previous years.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph A Hilinski, MD 305 E Jefferson St, Boise, ID 83712-6273 Ph: (208) 381-7330 | Joseph A Hilinski, MD 305 E Jefferson St, Boise, ID 83712-6273 Ph: (208) 381-7330 |
News Archive
Vemma has updated the Verve brand packaging to better align with the company's modern, premium and healthy look and feel. Rebranding projects included both Verve Energy Drink and Verve Energy Shot.
The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.
Pfizer Inc. today announced the commencement of a tender offer by its wholly owned subsidiary, Parker Tennessee Corp., for all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
"In the Horn of Africa, millions of people face each day without knowing if they will have clean water to drink or food to eat," but "American assistance to the Horn of Africa is beginning to make a difference, however, and in this series about water security in the Horn, we will showcase how water projects are helping people gain predictable access to clean water as a first step to gaining a foothold on a better life."
A new study suggests a growing number of U.S. adolescents lack antibodies that may help protect them later in life against an increasingly important cause of genital herpes. Published in The Journal of Infectious Diseases and available online, the findings show that fewer of today's teens have been exposed in their childhood to herpes simplex virus type 1 (HSV-1), a common cause of cold sores, than U.S. adolescents in previous years.
› Verified 3 days ago
Dr. Nathan D Meeker, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St, Boise, ID 83712 Phone: 208-381-2782 Fax: 208-381-3172 | |
Nicolas A Camilo, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St., Boise, ID 83712 Phone: 208-381-2782 Fax: 208-381-3172 | |
Heather Carew, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2645 | |
Dr. Frederick K Emge, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 100 E Idaho St, Suite 200, Boise, ID 83712 Phone: 208-381-7384 Fax: 208-381-7387 | |
Annis Wakelee Vargas, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1072 N Liberty Street, Ste 203, Boise, ID 83701 Phone: 208-302-5800 Fax: 208-302-5855 | |
Mrs. Lisa S Labor, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8610 W Overland Rd, Boise, ID 83709 Phone: 208-954-8711 Fax: 208-375-2217 | |
Mikelle E Mikesell, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8610 W Overland Rd, Boise, ID 83709 Phone: 208-954-8711 |